Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Biocogniv
AddedFeb 15, 2024
UpdatedJul 3, 2026
Biocogniv

Biocogniv

Acquired

AI-powered data analysis and optimization for enhanced clinical operations.

HQ
South Burlington, VT, US
Founded
2019
Accelerator
Y Combinator logoY CombinatorS20
Overview
Compare
Fundraising
Employees

Founded with a mission to revolutionize clinical operations, Biocogniv leverages AI-powered data analysis to enhance acute care diagnostics. The company aims to reduce preventable deaths in hospitals by enabling frontline providers to recognize acute conditions early through advanced AI and routine tests. Their core product focuses on real-time AI diagnostics, designed to identify critical health issues before they become irreversible, thereby optimizing clinical outcomes and operational efficiency.

Notable for receiving groundbreaking designation from the FDA, Biocogniv has made significant strides in the healthcare AI sector. The company's innovation engine is powered by FDA-grade AI and real-world data, ensuring high reliability and effectiveness. With a focus on acute care, Biocogniv's impact is evident in its potential to save lives by improving early diagnosis and intervention in hospital settings.

Biocogniv - Similar Companies

Caire Health logo

Caire Health

cairehealth.com

BioticsAI logo

BioticsAI

biotics.ai

CognitiveCare logo

CognitiveCare

cognitivecare.com

Ahead Project logo

Ahead Project

Scanbase logo

Scanbase

scanbase.com

BioSig AI Sciences logo

BioSig AI Sciences

Ainnova Tech logo

Ainnova Tech

ainnovatech.com

BioAI Health logo

BioAI Health

bioaihealth.com

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

Retina-Ai Health logo

Retina-Ai Health

PulseData logo

PulseData

pulsedata.io

Hippocratic AI logo

Hippocratic AI

hippocraticai.com

Regard logo

Regard

withregard.com

Cognoa logo

Cognoa

cognoa.com

Vitazi.ai logo

Vitazi.ai

vitazi.ai

Biocogniv - Quick Facts

Who are Biocogniv's competitors?

Companies similar to Biocogniv include Caire Health, BioticsAI, CognitiveCare and Ahead Project.

When was Biocogniv founded?

Biocogniv was founded in 2019.

Where is Biocogniv's headquarters located?

Biocogniv's headquarters is located in South Burlington, VT, US.

When was Biocogniv's last funding round?

Biocogniv's most recent funding round was for $5M (USD) in October 2023.

How much has Biocogniv raised to-date?

As of Oct 19, 2023, Biocogniv has raised a total of $11.4M (USD).

Biocogniv - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • AI Diagnostics
Tags
  • AI Operations
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software